As of Nov 27
| +0.19 / +8.26%|
The 2 analysts offering 12-month price forecasts for CorMedix Inc have a median target of 4.50, with a high estimate of 6.50 and a low estimate of 2.50. The median estimate represents a +80.72% increase from the last price of 2.49.
The current consensus among 2 polled investment analysts is to Buy stock in CorMedix Inc. This rating has held steady since November, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.